CN104645244A - Traditional Chinese medicine composition for treating atherosclerosis - Google Patents
Traditional Chinese medicine composition for treating atherosclerosis Download PDFInfo
- Publication number
- CN104645244A CN104645244A CN201510110696.8A CN201510110696A CN104645244A CN 104645244 A CN104645244 A CN 104645244A CN 201510110696 A CN201510110696 A CN 201510110696A CN 104645244 A CN104645244 A CN 104645244A
- Authority
- CN
- China
- Prior art keywords
- parts
- flos
- chinese medicine
- fructus
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 90
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 201000001320 Atherosclerosis Diseases 0.000 title abstract description 5
- 241000628997 Flos Species 0.000 claims abstract description 66
- 229940079593 drug Drugs 0.000 claims abstract description 32
- 241000220324 Pyrus Species 0.000 claims abstract description 23
- 235000021017 pears Nutrition 0.000 claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- 241000005787 Cistanche Species 0.000 claims abstract description 14
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 14
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 238000002360 preparation method Methods 0.000 claims description 37
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 28
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 28
- 210000000582 semen Anatomy 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 21
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000011347 resin Substances 0.000 claims description 15
- 229920005989 resin Polymers 0.000 claims description 15
- 241000208340 Araliaceae Species 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 241000242759 Actiniaria Species 0.000 claims description 13
- 241000218628 Ginkgo Species 0.000 claims description 13
- 235000011201 Ginkgo Nutrition 0.000 claims description 13
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 13
- 108010052008 colla corii asini Proteins 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 12
- 238000010828 elution Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 8
- 230000000274 adsorptive effect Effects 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- -1 electuary Substances 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 37
- 210000004369 blood Anatomy 0.000 abstract description 36
- 230000000694 effects Effects 0.000 abstract description 34
- 230000006870 function Effects 0.000 abstract description 26
- 208000002193 Pain Diseases 0.000 abstract description 21
- 210000003734 kidney Anatomy 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 20
- 208000024891 symptom Diseases 0.000 abstract description 18
- 210000002216 heart Anatomy 0.000 abstract description 17
- 210000004556 brain Anatomy 0.000 abstract description 5
- 230000003014 reinforcing effect Effects 0.000 abstract description 5
- 210000001835 viscera Anatomy 0.000 abstract description 4
- 239000002671 adjuvant Substances 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 240000003870 Ageratum houstonianum Species 0.000 abstract 1
- 241001083548 Anemone Species 0.000 abstract 1
- 241001061906 Caragana Species 0.000 abstract 1
- 241000871539 Choerospondias Species 0.000 abstract 1
- 235000005979 Citrus limon Nutrition 0.000 abstract 1
- 244000131522 Citrus pyriformis Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 244000046101 Sophora japonica Species 0.000 abstract 1
- 235000010586 Sophora japonica Nutrition 0.000 abstract 1
- 241000301400 Trogopterus Species 0.000 abstract 1
- 229940023019 aconite Drugs 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004789 organ system Anatomy 0.000 abstract 1
- 229940109850 royal jelly Drugs 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 26
- 235000019634 flavors Nutrition 0.000 description 26
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 17
- 201000010099 disease Diseases 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 11
- 238000009826 distribution Methods 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 210000003414 extremity Anatomy 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 206010022437 insomnia Diseases 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 206010033557 Palpitations Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 210000000115 thoracic cavity Anatomy 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 210000003141 lower extremity Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010008479 Chest Pain Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000002683 foot Anatomy 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000007958 sleep Effects 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010017577 Gait disturbance Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000013210 hematogenous Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010022562 Intermittent claudication Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000002302 brachial artery Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000007937 eating Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000023513 hiccough Diseases 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000021156 intermittent vascular claudication Diseases 0.000 description 2
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 210000002321 radial artery Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000001994 temporal artery Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000216 vascular lesion Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 210000003017 ductus arteriosus Anatomy 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000004744 fore-foot Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000009064 mailuoning Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 210000003137 popliteal artery Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000002465 tibial artery Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating atherosclerosis. According to the invention, mulberry, sophora japonica, lotus stamen, dodder seed, aconite root, black sesame, altai anemone rhizome, intermediate peashrub flower, caulis spatholobi, trogopterus dung, ageratum, achyranthes and donkey-hide gelatin are used in the raw material medicine as monarch and adjuvant drugs for preventing and treating atherosclerosis, complex pulse and depletion, reinforcing liver and kidney, nourishing blood and brain, dispelling cold and relieving pain; auxiliary choerospondias fruit, ginseng flower, lily, gingko leaf, flos albiziae, radix linderae leaf, desertliving cistanche, longan pulp, salvia miltiorrhiza, curcuma root, fresh pears, oranges, lemons and royal jelly are used as auxiliary drugs to enhance effects of the monarch-and-adjuvant drugs, so as to tranquilize mind by nourishing the heart, replenish body vitality, restore physical strength and improve immunity; and combination of the drugs has better effects in preventing and treating symptoms of patients with atherosclerosis, reducing or inhibiting systemic reactions, protecting functions of various organ systems, nourishing the five internal organs and reinforcing yin and the essence.
Description
Technical field
The present invention relates to the medicinal preparation containing deriving from plant, animal or raw mineral materials, particularly a kind of Chinese medicine composition for the treatment of arteriosclerosis and preparation method thereof.
Background technology
Arteriosclerosis is a kind of non-inflammation pathological changes of tremulous pulse, ductus arteriosus wall can be made to thicken, hardening, follows the string, luminal stenosis.Arteriosclerosis be with age and occur angiopathy, its rule normally adolescence occur, increase the weight of period to person in middle and old age, fall ill.Male is many compared with women, and primary disease increases gradually in China in recent years, becomes one of old people's main cause of death.
Clinical manifestation: arteriosclerotic performance depends mainly on the degree of ischemia of vascular lesion and afflicted organ, for early stage arteriosclerotic, Most patients nearly all without any clinical symptoms, development of hiding under being all in concealment state.For the arteriosclerotic in mid-term, the clinical symptoms such as Most patients all more or less listless and aching, the limping of had palpitation, chest pain, uncomfortable in chest, headache, dizziness, the cool fiber crops of extremity, extremity, vision reduction, hypomnesis, insomnia and dreamful sleep, different patients has different symptoms.Generally show as mental and flag, palpation body surface artery is as elongated, tortuous and hardening in Temporal Artery, radial artery, brachial artery etc. can find to broaden.
The traditional Chinese medical science thinks that many and inward invasion of pathogenic cold occur this disease, drinking and eating irregularly, and feelings will is forfeited one's integrity, and overstrain internal injury, the factors such as body deficiency due to old age are relevant, and pathogenesis has deficiency and excess two aspect.Show as: suffocating pain over the chest, very then chest pain radiating to the back, failing to sleep due to dyspnea is main symptom, or uncomfortable in chest, and breathe and owe smooth, severe one then has chest pain, severe patient chest pain radiating to the back, backache radiating to the heart.Stringy pulse or knot generation.
1. the cause of disease
(1) inward invasion of pathogenic cold is trembled with fear main spasm, and containment yang-energy, makes hematogenous blockage, sends out as primary disease
(2) drinking and eating irregularly intemperance of taking food, surfeit delicious food savoury, or be addicted to drink addicted to cigarette, cause spleen
gastric injury, transporting is lacked of proper care, accumulatively wet raise phlegm, and upper criminal ambition, checks heart-yang, functional activity of QI being not smooth, blockage of the cardiac vessels and send out for this reason sick.
(3) feelings will is forfeited one's integrity melancholy impairing the spleen, dysfunction of the spleen in transportation, poly-ly wets into expectorant; Depressed rage impairing the liver, the irritability stasis of blood is stagnant, very then stagnated QI transforming into fire, fluid transformed into phlegm by fire.The stagnation of QI and stagnation of phlegm all can make hematogenous blockage, blockage of the cardiac vessels, and send out as the thoracic obstruction.
(4) overstrain internal injury overstrain impairing the spleen,
insufficiency of the spleenlose fortune, QI and bloodization is raw passive, and heart arteries and veins loses supports and the thoracic obstruction; Or impairment of YANG of being overworked for a very long period, heart kidney yang is micro-, and agitate unable, Xiong Yang is depressed, invades in YIN-cold, hematogenous blockage and sending out as the thoracic obstruction.
(5) body deficiency due to old age is over fifty, kidney qi from half, essence and blood degradation,
insufficiency of kidney-YANGdecline, then can not inspire YANG of five ZANG-organs, deficiency of kidney-YIN, then can not moisten foster the five internal organs, heart arteries and veins loses to be sent out as the thoracic obstruction in replenishing vital QI with drugs of warm nature.
2. pathogenesis
The main pathogenesis of the thoracic obstruction is blockage of the cardiac vessels, and sick position is the heart, relates to liver, spleen, kidney, and lung etc. are dirty.The heart, liver,spleen,kidney, pulmonary air blood negative and positive are not enough, and heart arteries and veins loses supports, not Rong Ze pain, the numbness resistance heart arteries and veins such as the stagnation of QI, blood stasis, cold coagulation, phlegm-damp, stagnation of QI and blood may bring about pain.
Traditional Chinese medicine does not propose the concept of " arteriosclerosis ".The nomenclature principle of traditional Chinese medical science disease mainly with the cause of disease, pathogenesis, pathological product, sick position, primary symptom, sign for foundation.At Chinese medicine medium-sized artery sclerosis many genus " thoracic obstruction " category, the advantage of Chinese traditional treatment arteriosclerosis is that effect is better than simple western medical treatment, and life in patients is higher, and life span is also longer.
Summary of the invention
Technical problem to be solved by this invention is, provides that a kind of formula is simple, processing technology is easy, and the little and convenient drug administration of toxic and side effects, medicament is easy to manufacture, new drug with low cost.The present invention has enriching yin boost qi, blood circulation and channel invigorating, nourish heart effect that is active, warmly nourishing Yangqi; mainly for the discomfort of arteriosclerosis patient; the treatment of whole body relevant disease effectively can be taken into account while improving promoting extremities blood circulation; good prevention effect is had to the arteriosclerosis of whole body, angiostenosis; good protective effect is had to vitals such as the heart, brain, kidneys; be formed with very important effect to what prevent and treat coronary heart disease, myocardial infarction and cerebral thrombosis, improve the quality of life of patient.The present invention adopts the Chinese crude drug of different properties, has carried out scientific compatibility, and can reach desirable therapeutic effect, safety, processing technology is easy, and toxic and side effects is little, and convenient drug administration, medicament is easy to manufacture, with low cost.
For solving the problems of the technologies described above, the invention provides a kind of Chinese medicine composition for the treatment of arteriosclerosis, its crude drug is with Fructus Mori, Flos Sophorae, Stamen Nelumbinis, Semen Cuscutae, Radix Aconiti Lateralis Preparata, Semen Sesami Nigrum, Rhizoma Anemones Altaicae, Flos Caraganae intermediae, Caulis Spatholobi, Oletum Trogopterori, Herba Pogostemonis, Radix Achyranthis Bidentatae, arteriosclerosis prevented and treated by the medicine that Colla Corii Asini is the monarch and his subjects, multiple arteries and veins takes off admittedly, the liver and the kidney tonifying, nourish blood beneficial brain dispersing cold for relieving pain, with Fructus Choerospondiatis, Flos Ginseng, Flos Lilii viriduli, Folium Ginkgo, Flos Albiziae, Folium Linderae strychnifoliae, Herba Cistanches, Arillus Longan, Radix Salviae Miltiorrhizae, Radix Curcumae, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae and the medicine of Lac regis apis for assisting a ruler in governing a country, strengthen effect of monarch-minister drug, tranquilizing by nourishing the heart, supplement vitality of human body, regain one's strength, improve immunity, all medicines share better prevents and treats arteriosclerosis patients symptomatic, alleviate or suppress general reaction, protect each tract function, support the five internal organs, YIN nourishing benefit vital essence.
The property of medicine and the pharmacology of medicine selected by the present invention are respectively:
Fructus Mori:
[nature and flavor] are sweet, are slightly cold; GUIXIN, liver, kidney channel.
[function cures mainly] controls hepatic and renal YIN deficiency, sends and takes off, constipation, and order is dark, tinnitus, former infections, articular instability.It is improved skin (comprising scalp) blood supply, nutrition skin, makes the effects such as the delicate and black hair of skin, and can slow down aging.Fructus Mori is that middle-aged and elderly people is healthy and strong U.S. face, antidotal good fruit and good medicine.Normal food Fructus Mori can improving eyesight, the symptom that relieving eye strain is dry and astringent.Fructus Mori has immunologic enhancement.Fructus Mori has effect of gain to spleen, has potentiation, can prevent human body to hemolytic reaction
arteriosclerosis, skeletal joint sclerosis, promote
metabolism; Fructus Mori can promote
erythrocytegrowth, prevent
leukocytereduce, and to treatment
diabetes,
anemia,
hypertension,
hyperlipidemia,
coronary heart disease,
neurastheniaetc. disease, there is auxiliary curative effect.Fructus Mori has the effects such as promoting the production of body fluid to quench thirst, facilitating digestion, help defecation, and proper amount of edible can promote gastric secretion, stimulates enterokinesia and removes scorching.The traditional Chinese medical science is thought, Fructus Mori is sweet in flavor and cold in property, there is the liver and the kidney tonifying, intestine moistening of promoting the production of body fluid, the effect such as black hair improving eyesight.
Flos Sophorae: nature and flavor with return through: bitter in the mouth, be slightly cold.Return liver, large intestine channel.Function with cure mainly: cooling blood for hemostasis, blood pressure lowering.For spitting blood, have blood in stool, bleeding hemorrhoids, hematuria metrorrhagia, hypertension.Suitable amount used externally.Many parch to black that stops blooding are used; The many raw use of expelling phlegm for arresting cough.
Stamen Nelumbinis:
[nature and flavor] are sweet, puckery, flat.
[return through] GUIXIN, kidney channel.
[function cures mainly] reinforcing the kindey to control nocturnal emission.For emission and spermatorrhea, leukorrhagia,
urinefrequently.
Semen Cuscutae:
[nature and flavor] Gan Xinping, enters liver, kidney channel.
[function cures mainly] the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, antiabortive.For caused by liver and kidney deficiency, soreness of waist and knee joint, impotence and seminal emission, frequent urination and enuresis, two blurred visions are dark, the diseases such as frequent fetal movement.
Radix Aconiti Lateralis Preparata:
[nature and flavor] are pungent, sweet, hot greatly; Poisonous; GUIXIN, kidney, spleen channel.
[function]
recuperating depleted YANG and rescuing the patient from collapse, mend fire supporing yang, dispersing cold for relieving pain." for recuperating depleted YANG and rescuing the patient from collapse first product medicine "
[curing mainly] for excessive YIN keeping YANG externally, profuse sweating
yANG-depletion, vomiting and diarrhoea, it is inverse to faint, cold extremities faint pulse,
trusted subordinatecold type of pain, cold-dysentery, beriberi
edema, anemofrigid-damp arthralgia, sexual impotence, cold womb,
deficiency and coldnessvomit and diarrhoea, YIN-cold edema, yang deficiency diseases caused by exogenous pathogenic factor, the disease of carbuncle of yin nature skin infection and all chronic diseaseses.
Semen Sesami Nigrum:
[nature and flavor] are flat, sweet in the mouth.
[effect] invigorating the liver and kidney, benefiting essence-blood, intestine moistening is dry; For dizziness and blurred vision, Hiccough and deaf, early whitening of beard and hair, post disease alopecia, dryness of the intestine constipation.
Rhizoma Anemones Altaicae:
[meridian distribution of property and flavor] is pungent, temperature.
[function cures mainly] has expectorant of having one's ideas straightened out, the function of being amusing of calming the nerves., inappetence vexed for calentura stupor, epilepsy, neurosis, Hiccough and deaf, breast abdominal distention.Carbuncle skin ulcer tinea is controlled in external.
Flos Caraganae intermediae:
[nature and flavor] are sweet, temperature.
[function cures mainly] nourishing YIN and benefiting blood.Control hypertension, dizziness.
Caulis Spatholobi:
[meridian distribution of property and flavor] is bitter, sweet, temperature.Return liver, kidney channel.
[function cures mainly] enriches blood, and invigorates blood circulation, dredging collateral.For menoxenia, blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia.
Oletum Trogopterori:
[nature and flavor] are sweet, temperature.
[function cures mainly] promoting blood circulation to remove blood stasis, parch to black stops blooding.Have a pain for trusted subordinate's congestion, dysmenorrhea, blood stasis amenorrhea, puerperal abdominalgia with blood stasis; Parch to black controls metrostaxis; Traumatic injury is controlled in external, Serpentis, insect bite wound.It is logical that Oletum Trogopterori hardship lets out temperature, and " tonneau gaseous pulse ", " general rule is not bitterly.”
Herba Pogostemonis: pungent, tepor.Return spleen, stomach, lung meridian.Function cures mainly: eliminating turbid pathogen with aromatics, and appetizing preventing or arresting vomiting, delivers expelling summer-heat.For turbid damp obstructing in middle-JIAO, gastral cavity painful abdominal mass is vomitted, and heat-damp in summer asthenia is not uncomfortable in chestly relaxed, and cold-damp closes summer-heat, and stomachache is vomited and diarrhoea, nasosinusitis headache." kind reason Central Region turbid damp sputum, is fast stomach of being amusing, vibrates clear positive quality goods for Herba Pogostemonis, delicate fragrance tepor." not Lu " controls the swollen person of edema due to wind pathogen poison, and dispel turbid damp, self energy clear the course also.1. the effect of antifungic action 2. anti-leptospira effect 3. antivirus action 4. pairs of digestive system.
Radix Achyranthis Bidentatae:
[meridian distribution of property and flavor] bitter in the mouth, acid, flat; Return liver, kidney channel.
[function cures mainly] invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards.For soreness of waist and knee joint, muscles and bones is unable, amenorrhea lump in the abdomen, dizziness due to hyperactivity of liver-YANG.
Colla Corii Asini:
[nature and flavor, return through] are sweet, flat.Return lung, liver, kidney channel.
[effect] enriches blood, hemostasis, nourshing Yin and drynsessmoistening prescription.
[composition] donkey skin.Adjuvant: crystal sugar, yellow wine, Oleum Glycines.
[character] this product is rectangle or square block, and pitchy is glossy.Matter is hard and crisp, and section light, fragment is looked in brown translucent illumination.Feeble QI, taste is micro-sweet.
[function cures mainly] to be enriched blood YIN nourishing, is moisturized, hemostasis.For blood deficiency and yellow complexion, dizzy cardiopalmus, dysphoria and insomnia, xeropulmonary cough.
Fructus Choerospondiatis:
[meridian distribution of property and flavor]
sweet,
acid,
flat.
[function] circulation of qi promoting
invigorate blood circulation, nourish heart, calm the nerves, anti-
cardiac muscleischemia, the effects such as cardiac function protecting.For qi depression to blood stasis, the thoracic obstruction is had a pain, shortness of breath and palpitation, irritability.
Flos Ginseng:
[nature and flavor]: bitterness Hui Tian, have the pungent sweet taste of Radix Ginseng.
[function]: supplement vitality of human body, regain one's strength, strengthens body immunity.
Flos Lilii viriduli:
[nature and flavor] Bulbus Lilii sweet in the mouth, cold nature; GUIXIN, lung meridian.
[function cures mainly] nourishing YIN and moistening the lung, clearing away heart-fire for tranquillization.For deficiency of YIN chronic cough, sputum mixed with blood, fidgets due to deficiency is palpitated with fear, insomnia and dreamful sleep, absentminded.Have nourishing YIN and moistening the lung cough-relieving effect, for the cough caused by dryness-heat of deficiency of lung-YIN, sputum mixed with blood, as all sorts of flowers cream.Control chronic cough of deficiency lung, chronic cough is spat blood, as baihe gujin decoction.Have clearing away heart-fire for tranquillization effect, unclear for calentura waste heat, fidgets due to deficiency is palpitated with fear, insomnia and dreamful sleep etc.
Folium Ginkgo:
[meridian distribution of property and flavor] bitter in the mouth, puckery, flat; The benefit heart is astringed the lung, removing dampness antidiarrheal.
[function cures mainly] is uncomfortable in chest pained, severe palpitation, and phlegm dyspnea is coughed, dysentery, leucorrhea.
Flos Albiziae:
There is calming effects, mainly control the effects such as pent-up is uncomfortable in chest, insomnia forgetfulness, nourishing YIN and invigorating YANG, ophthalmic, neurasthenia.Shu Yu, regulates the flow of vital energy, and calms the nerves, active.Control pent-up uncomfortable in chest, insomnia, forgetful, wind-fire ophthalmic, blurring of vision, pharyngalgia, carbuncle, traumatic injury pain.
Folium Linderae strychnifoliae:
[meridian distribution of property and flavor] is pungent, temperature enters lung, spleen, kidney three warp;
[effect] warming middle-JIAO, regulates the flow of vital energy, pain relieving.Control pathogenic cold in abdomen pain, the sliding number of urine, food stagnation, rheumatic arthritis.
Herba Cistanches:
[nature and flavor] are warm in nature, sweet in the mouth, salty;
[effect] supports the five internal organs, reinforcing YIN-essence, beneficial vital essence.
Arillus Longan:
[nature and flavor] are warm in nature, and taste is sweet.
[function cures mainly] invigorating the heart and spleen, nourishing blood to tranquillize the mind.For insufficiency of vital energy and blood, severe palpitation, forgetful insomnia, blood deficiency and yellow complexion.
Radix Salviae Miltiorrhizae:
[meridian distribution of property and flavor] is bitter, is slightly cold.GUIXIN, Liver Channel.
[function cures mainly] stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness.For menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris." book on Chinese herbal medicine justice ": Radix Salviae Miltiorrhizae, being slightly cold of " herbal classic " meaning, TAO Hong-Jing has doubted it by mistake, and Miao's secondary alcohol also doubts it, and stupid to a stone is transform tepor into." herbal classic ": main trusted subordinate's pathogen, borborygmus are faint as leaked water, and cold and heat gather; Broken disease, except abdominal mass, stops stuffy sensation with restlessness, QI invigorating." WU Pu Bencao ": control cardiac and abdominal pain." not Lu ": nourish blood, remove trusted subordinate's obstinate disease stagnation of QI, stiffness along the spinal column, foot numbness; Except wind, Xing stays heat, takes sharp people for a long time.TAO Hong-Jing: stain beverage it, treat migratory arthralgia." property of medicine opinion ": control flaccidity of the lower limbs, pain numbness, main attacked by pestiferous factors; Control stomachache, gas is done sound ring and is shouted." Japan hanako materia medica ": sedate of reposing, tonneau GUAN-pulse.Control cold and hot labor, arthralgia, extremity are unsuccessful; Evacuation of pus pain relieving, granulation promoting is put on flesh; Broken stagnated blood, mends new hemopoietic; Peaceful tire, fall stillborn fetus; Under hemostasis metrorrhagia and leukorrhagia, adjust married woman's passages through which vital energy circulates irregular, blood evil thought is tired of; Malignant boil scabies, wart is gone to live in the household of one's in-laws on getting married toxic swelling, erysipelas; Headache, acute conjunctivitis, hot temperature is mad vexed." the southern regions of the Yunnan Province book on Chinese herbal medicine ": reinforcing the heart sedate, calming heart and tranquilizing mind.Control forgetful palpitation with a distress feeling, palpitation with fear is insomnia." detailed outline ": invigorate blood circulation, logical percardium.Control colic." choosing of Yunnan Chinese herbal medicine ": promoting blood circulation to remove blood stasis, sedation-analgesia.Control menoxenia, dysmenorrhea, rheumatic arthralgia, metrorrhagia, spit blood, mastitis, carbuncle.
Radix Curcumae:
[meridian distribution of property and flavor] is pungent, bitter, cold; GUIXIN, lung, Liver Channel.
[effect] promoting blood circulation and stopping pain, dispersing the stagnated live-QI to relieve the stagnation of QI, removing heat from blood clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.
Fresh pears:
[meridian distribution of property and flavor] sweet in the mouth is sour, cool in nature, enters lung, stomach warp;
[function] containing compositions such as more glycocide and tannic acids, can promote the production of body fluid, heat clearing away, expelling phlegm for arresting cough, have maintenance action to throat.
Fructus Citri tangerinae:
[meridian distribution of property and flavor] sweet in the mouth is sour, cool in nature, enters lung, stomach warp;
[function] has appetizing and regulates the flow of vital energy, effect of relieving cough and moistening lung, cures mainly very thirsty in septum pectorale stagnation of QI, mouth, cough due to lung-heat etc.
Fructus Citri Limoniae:
[meridian distribution of property and flavor] sour in the mouth is sweet, property is flat, enters liver, stomach warp.
[function] has preventing phlegm from forming and stopping coughing, promotes the production of body fluid, effect of spleen invigorating; Mainly treating bronchitis, pertussis, vitamin C deficiency, heatstroke excessive thirst, inappetence, pregnant woman's disorder of stomach-QI, poor appetite, eructation etc.
Lac regis apis:
[nature and flavor] sweet acid, flat.
[function cures mainly] nourishes, strong, the liver benefiting, spleen invigorating.Weak after curing the disease, infantile malnutrition, old asthenia, infectious hepatitis, hypertension, rheumatic arthritis, duodenal ulcer.
For solving the problems of the technologies described above, the invention provides a kind of Chinese medicine composition for the treatment of arteriosclerosis, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of various crude drug is: Fructus Mori 10-20 part, Flos Sophorae 10-20 part, Stamen Nelumbinis 10-20 part, Semen Cuscutae 10-20 part, Radix Aconiti Lateralis Preparata 10-20 part, Semen Sesami Nigrum 10-20 part, Rhizoma Anemones Altaicae 10-20 part, Flos Caraganae intermediae 10-20 part, Caulis Spatholobi 10-20 part, Oletum Trogopterori 10-20 part, Herba Pogostemonis 10-20 part, Radix Achyranthis Bidentatae 10-20 part, Colla Corii Asini 10-20 part, Fructus Choerospondiatis 10-20 part, Flos Ginseng 10-20 part, Flos Lilii viriduli 10-20 part, Folium Ginkgo 10-20 part, Flos Albiziae 10-20 part, Folium Linderae strychnifoliae 10-20 part, Herba Cistanches 10-20 part, Arillus Longan 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Radix Curcumae 10-20 part, fresh pears 10-20 part, Fructus Citri tangerinae 10-20 part, Fructus Citri Limoniae 10-20 part, Lac regis apis 10-20 part.
For solving the problems of the technologies described above, the invention provides a kind of Chinese medicine composition for the treatment of arteriosclerosis, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of various crude drug is: Fructus Mori 14-18 part, Flos Sophorae 14-18 part, Stamen Nelumbinis 14-18 part, Semen Cuscutae 14-18 part, Radix Aconiti Lateralis Preparata 14-18 part, Semen Sesami Nigrum 14-18 part, Rhizoma Anemones Altaicae 14-18 part, Flos Caraganae intermediae 14-18 part, Caulis Spatholobi 14-18 part, Oletum Trogopterori 14-18 part, Herba Pogostemonis 14-18 part, Radix Achyranthis Bidentatae 14-18 part, Colla Corii Asini 14-18 part, Fructus Choerospondiatis 14-18 part, Flos Ginseng 14-18 part, Flos Lilii viriduli 14-18 part, Folium Ginkgo 14-18 part, Flos Albiziae 14-18 part, Folium Linderae strychnifoliae 14-18 part, Herba Cistanches 14-18 part, Arillus Longan 14-18 part, Radix Salviae Miltiorrhizae 14-18 part, Radix Curcumae 14-18 part, fresh pears 14-18 part, Fructus Citri tangerinae 14-18 part, Fructus Citri Limoniae 14-18 part, Lac regis apis 14-18 part.
For solving the problems of the technologies described above, the invention provides a kind of Chinese medicine composition for the treatment of arteriosclerosis, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of various crude drug is: 16 parts, Fructus Mori, 16 parts, Flos Sophorae, Stamen Nelumbinis 16 parts, Semen Cuscutae 16 parts, Radix Aconiti Lateralis Preparata 16 parts, Semen Sesami Nigrum 16 parts, Rhizoma Anemones Altaicae 16 parts, Flos Caraganae intermediae 16 parts, Caulis Spatholobi 16 parts, Oletum Trogopterori 16 parts, Herba Pogostemonis 16 parts, Radix Achyranthis Bidentatae 16 parts, 16 parts, Colla Corii Asini, Fructus Choerospondiatis 16 parts, Flos Ginseng 16 parts, Flos Lilii viriduli 16 parts, Folium Ginkgo 16 parts, Flos Albiziae 16 parts, Folium Linderae strychnifoliae 16 parts, Herba Cistanches 16 parts, Arillus Longan 16 parts, Radix Salviae Miltiorrhizae 16 parts, Radix Curcumae 16 parts, fresh pears 16 parts, Fructus Citri tangerinae 16 parts, 16 parts, Fructus Citri Limoniae, Lac regis apis 16 parts.
For solving the problems of the technologies described above, the present invention also provides a kind of preparation method for the treatment of the Chinese medicine composition of arteriosclerosis, and described Chinese medicine preparation dosage form is that the preparation method of capsule comprises:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, puts into 10 times of water gagings by surplus stock, heating and refluxing extraction 3 times, each 45 minutes ~ 1 hour, is merged by 3 extracting solution and leaves standstill;
Step c, by the merging of above-mentioned two kinds of filtrates, decompression recycling ethanol to be concentrated into liquor strength be 0.4g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.06; Above-mentioned filtrate is the macroporous adsorptive resins of 10L through volume, first uses deionized water or the distilled water eluting of 10 times of resin column volumes, then uses 95% ethanol elution of 5 times of resin column volumes, collects ethanol elution, removes solvent, obtains raw material medicated powder, incapsulate.One time four, three times on the one.
For solving the problems of the technologies described above, the present invention also provides a kind of preparation method for the treatment of the Chinese medicine composition of arteriosclerosis, and described Chinese medicine preparation dosage form is that the preparation method of oral liquid comprises:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, by surplus stock medicine, is placed in decoction pot, first time adds 3 times of water gagings, soak 3 hours, decoct 20-30 minute, leach decocting liquid, second time adds 2 times of water gagings again, decoct 20-30 minute, twice decocting liquid mixing adjusted and add extracting solution subharmonic again in step a all afterwards, being concentrated into liquor strength is 0.4g crude drug/mL oral liquid, filling device bottle, obtains oral liquid.Each one of morning, noon and afternoon.
For solving the problems of the technologies described above, the present invention also provides a kind of dosage form for the treatment of the Chinese medicine composition of arteriosclerosis, and pharmaceutical dosage form can also be: sugar coated tablet, film coated tablet, enteric coated tablet, oral liquid, granule, electuary, powder, sublimed preparation, solution, suppository, plaster, syrup.
Detailed description of the invention:
Embodiment 1, formula: Fructus Mori 10g, Flos Sophorae 10g, Stamen Nelumbinis 10g, Semen Cuscutae 10g, Radix Aconiti Lateralis Preparata 10g, Semen Sesami Nigrum 10g, Rhizoma Anemones Altaicae 10g, Flos Caraganae intermediae 10g, Caulis Spatholobi 10g, Oletum Trogopterori 10g, Herba Pogostemonis 10g, Radix Achyranthis Bidentatae 10g, Colla Corii Asini 10g, Fructus Choerospondiatis 10g, Flos Ginseng 10g, Flos Lilii viriduli 10g, Folium Ginkgo 10g, Flos Albiziae 10g, Folium Linderae strychnifoliae 10g, Herba Cistanches 10g, Arillus Longan 10g, Radix Salviae Miltiorrhizae 10g, Radix Curcumae 10g, fresh pears 10g, Fructus Citri tangerinae 10g, Fructus Citri Limoniae 10g, Lac regis apis 10g;
Preparation method:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, by surplus stock medicine, is placed in decoction pot, first time adds 3 times of water gagings, soak 3 hours, decoct 20-30 minute, leach decocting liquid, second time adds 2 times of water gagings again, decoct 20-30 minute, twice decocting liquid mixing adjusted and add extracting solution subharmonic again in step a all afterwards, being concentrated into liquor strength is 0.4g crude drug/mL oral liquid, filling device bottle, obtains oral liquid.Each one of morning, noon and afternoon.
Treatment model case:
Lee, man, 50 years old, main cause " intermittent claudication increases the weight of 1 year in 5 years " is admitted to hospital.Before 5 years there is left lower extremity intermittent claudication in patient, and pulsation of foot dorsal artery disappears. walk about 300 meters.Go to a doctor and do color-Doppler ultrasound in locality province Grade A hospital and show: “ left popliteal artery Serious Stenosis, intra-arterial atherosclerosis plaque forming "; diagnosis " for left lower extremity atherosclerotic occlusive disease " gives operative treatment; postoperatively give oral invention formulation always; after 15 days, sign recovers normal; after consolidate one month again, do not recur so far.
Embodiment 2, formula: Fructus Mori 14g, Flos Sophorae 14g, Stamen Nelumbinis 14g, Semen Cuscutae 14g, Radix Aconiti Lateralis Preparata 14g, Semen Sesami Nigrum 14g, Rhizoma Anemones Altaicae 14g, Flos Caraganae intermediae 14g, Caulis Spatholobi 14g, Oletum Trogopterori 14g, Herba Pogostemonis 14g, Radix Achyranthis Bidentatae 14g, Colla Corii Asini 14g, Fructus Choerospondiatis 14g, Flos Ginseng 14g, Flos Lilii viriduli 14g, Folium Ginkgo 14g, Flos Albiziae 14g, Folium Linderae strychnifoliae 14g, Herba Cistanches 14g, Arillus Longan 14g, Radix Salviae Miltiorrhizae 14g, Radix Curcumae 14g, fresh pears 14g, Fructus Citri tangerinae 14g, Fructus Citri Limoniae 14g, Lac regis apis 14g.
Preparation method:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, puts into 10 times of water gagings by surplus stock, heating and refluxing extraction 3 times, each 45 minutes ~ 1 hour, is merged by 3 extracting solution and leaves standstill;
Step c, by the merging of above-mentioned two kinds of filtrates, decompression recycling ethanol to be concentrated into liquor strength be 0.4g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.06; Above-mentioned filtrate is the macroporous adsorptive resins of 10L through volume, first uses deionized water or the distilled water eluting of 10 times of resin column volumes, then uses 95% ethanol elution of 5 times of resin column volumes, collects ethanol elution, removes solvent, obtains raw material medicated powder, incapsulate.One time four, three times on the one.
Treatment model case:
Sex: man, age: 52 years old.Medical history: December in 2014 evening on the 26th, middle appearance of sleeping is had palpitation, and getting up early feels that left hand left foot is numb, and left side speed of walking slows down, and is brain CT and does not find abnormal.The cervical vertebra both sides of feeling the 3rd day evening are very tight, and both shoulders are very heavy, and be again brain CT in time, result is without exception.Just occur current state subsequently: extremity are stiff, bent time length can not be stretched, and straight time length can not bend.Numb limbs and tense tendons is unable, and particularly sole numbness is walked unstable, dragging step walks, and two lower limb overweight two upper limb.Muscular tension is very high, tendon reflex extremely resist into, two forefoot is useless, does not stress.Finally be diagnosed as: arteriosclerosis, oral medicine of the present invention is after 14 days, and symptom is improved, and after two weeks, all diseases disappear, antisecosis, and spiritual pure, adheres to medication, consolidate curative effect, prevention of recurrence.Follow up a case by regular visits to and have no recurrence in more than 2 years.
Embodiment 3, formula: Fructus Mori 16g, Flos Sophorae 16g, Stamen Nelumbinis 16g, Semen Cuscutae 16g, Radix Aconiti Lateralis Preparata 16g, Semen Sesami Nigrum 16g, Rhizoma Anemones Altaicae 16g, Flos Caraganae intermediae 16g, Caulis Spatholobi 16g, Oletum Trogopterori 16g, Herba Pogostemonis 16g, Radix Achyranthis Bidentatae 16g, Colla Corii Asini 16g, Fructus Choerospondiatis 16g, Flos Ginseng 16g, Flos Lilii viriduli 16g, Folium Ginkgo 16g, Flos Albiziae 16g, Folium Linderae strychnifoliae 16g, Herba Cistanches 16g, Arillus Longan 16g, Radix Salviae Miltiorrhizae 16g, Radix Curcumae 16g, fresh pears 16g, Fructus Citri tangerinae 16g, Fructus Citri Limoniae 16g, Lac regis apis 16g.
Preparation method:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, puts into 10 times of water gagings by surplus stock, heating and refluxing extraction 3 times, each 45 minutes ~ 1 hour, is merged by 3 extracting solution and leaves standstill;
Step c, by the merging of above-mentioned two kinds of filtrates, decompression recycling ethanol to be concentrated into liquor strength be 0.4g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.06; Above-mentioned filtrate is the macroporous adsorptive resins of 10L through volume, first uses deionized water or the distilled water eluting of 10 times of resin column volumes, then uses 95% ethanol elution of 5 times of resin column volumes, collects ethanol elution, removes solvent, obtains raw material medicated powder, incapsulate.One time four, three times on the one.
Treatment model case: patient marquis so-and-so, in 72 years old this year, suffering from the multiple diseases such as hypertension, diabetes, cholecystitis, cholelithiasis, all have plenty medicine everyday, is very painful.Medical history brief introduction: when January in this year, left foot starts pain, then occurred there is erosion between redness, toe, and pain is more than round the clock.To when districts and cities' hospitalize, be diagnosed as " vasculitis ", the treatment several months does not all feel any better.Then forward provincial hospital to, done B ultrasonic, contrast examination, be diagnosed as " double-legged arterial obliterans of lower extremity ", the amputation of suggestion corrective surgery.But family members considers old man's long life, postoperative life inconvenience, and limbs have been followed old man decades, can not accept inwardly and do not agree to amputation.After give oral Chinese medicine of the present invention after 40 days, symptom is improved, and two lower limb skin temperature color of the leather recovers normal, by original lame distance be 5 meters bring up to 600 meters after just there is symptom.Current patient actively prepares stem cell transplantation operation, sets up and enrich Doppler flow mapping around suffering limb blood vessel, fundamentally solves blood vessel ischemia problem, avoids Relapse rate to show effect.
Embodiment 4, formula: Fructus Mori 18g, Flos Sophorae 18g, Stamen Nelumbinis 18g, Semen Cuscutae 18g, Radix Aconiti Lateralis Preparata 18g, Semen Sesami Nigrum 18g, Rhizoma Anemones Altaicae 18g, Flos Caraganae intermediae 18g, Caulis Spatholobi 18g, Oletum Trogopterori 18g, Herba Pogostemonis 18g, Radix Achyranthis Bidentatae 18g, Colla Corii Asini 18g, Fructus Choerospondiatis 18g, Flos Ginseng 18g, Flos Lilii viriduli 18g, Folium Ginkgo 18g, Flos Albiziae 18g, Folium Linderae strychnifoliae 18g, Herba Cistanches 18g, Arillus Longan 18g, Radix Salviae Miltiorrhizae 18g, Radix Curcumae 18g, fresh pears 18g, Fructus Citri tangerinae 18g, Fructus Citri Limoniae 18g, Lac regis apis 18g.
Preparation method:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, puts into 10 times of water gagings by surplus stock, heating and refluxing extraction 3 times, each 45 minutes ~ 1 hour, is merged by 3 extracting solution and leaves standstill;
Step c, by the merging of above-mentioned two kinds of filtrates, decompression recycling ethanol to be concentrated into liquor strength be 0.4g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.06; Above-mentioned filtrate is the macroporous adsorptive resins of 10L through volume, first uses deionized water or the distilled water eluting of 10 times of resin column volumes, then uses 95% ethanol elution of 5 times of resin column volumes, collects ethanol elution, removes solvent, obtains raw material medicated powder, incapsulate.One time four, three times on the one.
Treatment model case: female's Hao medical history brief introduction in 72 years old: right foot is sent out cool 3 months, occurs difficulty in walking afterwards, walk 300 meters afterwards sensation shank suppress swollen, occur pain at night, once defeated MAILUONING and Treated with Radix Salviae Miltiorrhizae, the state of an illness slightly takes a turn for the better.But pain increases the weight of after 10 days, night can only be interrupted sleep, carrys out my institute's treatment.Outpatient service is looked into: toes skin cyanosis color, and left first toe has a ulceration, and leg raising straight sag test is positive, and instep and posterior tibial artery are beaten faint, and blood glucose is not high.Diagnosis: atherosclerotic occlusive disease.Treatment: oral Chinese medicine preparation of the present invention, treat patient's transference cure after 21 days, healing is left hospital, after consolidate one month again, do not recur so far.
Embodiment 5, formula:
Fructus Mori 20g, Flos Sophorae 20g, Stamen Nelumbinis 20g, Semen Cuscutae 20g, Radix Aconiti Lateralis Preparata 20g, Semen Sesami Nigrum 20g, Rhizoma Anemones Altaicae 20g, Flos Caraganae intermediae 20g, Caulis Spatholobi 20g, Oletum Trogopterori 20g, Herba Pogostemonis 20g, Radix Achyranthis Bidentatae 20g, Colla Corii Asini 20g, Fructus Choerospondiatis 20g, Flos Ginseng 20g, Flos Lilii viriduli 20g, Folium Ginkgo 20g, Flos Albiziae 20g, Folium Linderae strychnifoliae 20g, Herba Cistanches 20g, Arillus Longan 20g, Radix Salviae Miltiorrhizae 20g, Radix Curcumae 20g, fresh pears 20g, Fructus Citri tangerinae 20g, Fructus Citri Limoniae 20g, Lac regis apis 20g.
Preparation method:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, by surplus stock medicine, is placed in decoction pot, first time adds 3 times of water gagings, soak 3 hours, decoct 20-30 minute, leach decocting liquid, second time adds 2 times of water gagings again, decoct 20-30 minute, twice decocting liquid mixing adjusted and add extracting solution subharmonic again in step a all afterwards, being concentrated into liquor strength is 0.4g crude drug/mL oral liquid, filling device bottle, obtains oral liquid.Each one of morning, noon and afternoon.
Model case: Zhang, be diagnosed as the mental disorder that cerebral arteriosclerosis occurs together for 50 years old, and always forget east at the beginning and forget west, buy vegetables and be not with money, go out and be not with key, these are all common occurrences.She became and more went against accepted conventions afterwards, was often will forget upper one minute next minute of what someone said.Household is afraid of dull-witted, and go to hospital to check, make a definite diagnosis: the mental disorder that cerebral arteriosclerosis occurs together, this disease needs most conditioning, and oral Chinese medicine preparation of the present invention 20 days symptoms are obviously improved, after consolidated again one month, rehabilitation, does not recur so far.
Pharmacological toxicity is tested
1, acute toxicity test
Application mice carries out acute toxicity testing and shows: Mouse oral gavage Chinese medicine preparation of the present invention, under 488.8g crude drug/kg dosage, after administration, mice occurs that light activity reduces, 1 hours recovers normal, Continuous Observation 7 days after administration, none animal dead, its overall health of patients, diet, take the photograph water, urine and body weight increase all normal, experimental result shows: the maximum dosage-feeding of Mouse oral gavage Traditional Chinese medicine preparation capsule agent of the present invention is 488.8g crude drug/kg/d (LD 50 > 488.8g crude drug/kg).Chinese medicine preparation clinical application every day total amount of the present invention is 0.1g crude drug/kg/d; By weighing machine, the dosis tolerata of mouse stomach Chinese medicine preparation of the present invention is 4888 times of clinical patient.Point out this medicine acute toxicity low, clinical drug safety.
2, long term toxicity test
Select SD rat, give the Chinese medicine preparation of the present invention of variable concentrations (18.0,6.0,2.0g crude drug/kg), every day gavage once, continuous 90 days, within after last administration 24 hours, respectively group is alive kills 1/2 animal (male and female half and half), and all the other 1/2 animals continue observations 2 weeks rear living and kill.Duration of test observes outward appearance, general behavior, food ration, the body weight change of animal, within after administration 90 days, within 2 weeks, carries out the index checking such as hematology's (RBC, HB, reticulocyte, PLT, CT, WBC and classification) and blood biochemical (AST, ALT, ALP, Glu, BUN, Crea, TP, T.BIL, ALB, CHOL), urine biochemistry, organ coefficient, histopathology with drug withdrawal.Result of the test shows: invention formulation is good at high, medium and low dosage treated animal general state, and outward appearance sign, behavioral activity, food-intake and body weight increase change all without exception; Three dosage groups and matched group hematological examination, blood biochemical analysis, urine biochemical analysis all in normal range, without significant difference between group; Each group of main organs histopathological examination shows no obvious abnormalities.These parameters drug withdrawal also had no change after 2 weeks.This test dosage is respectively 180,60,20 times of clinical medicine dose, rat is had no significant effect in high, medium and low three dosage (18.0,6.0,2.0g crude drug/kg) administration in continuous 90 days according to result of the test Chinese medicine preparation of the present invention, without clear and definite toxicity target organ and sensitive indicator, convalescent period observation also has no retardance toxic reaction, points out the dose safety of Chinese medicine preparation clinical practice of the present invention higher.
3, animal local excitation test:
The allergic reaction on guinea pigs of invention formulation and capsule Rat-rectum medication irritation test.Result shows: skin anaphylactic test, high dose group 0.8g (medicated powder)/kg, low dose group 0.1g (medicated powder)/kg, be equivalent to 20 times, 2.5 times that intend clinical people's consumption [0.04g (medicated powder)/kg] respectively, through percutaneous drug delivery, be showed no animal and produce allergy; Rectal application irritation test high dose group 5.0g (medicated powder)/kg, low dose group 3.2g (medicated powder)/kg, be equivalent to 125,80 times that intend clinical people's consumption respectively, mucous membrane of rectum is observed all without phenomenons such as hyperemia, edema in official hour, histopathologic examination compares no significant difference with blank group, have no and occur obvious irritative response, often organize its overall health of patients of Some Animals of retention, body weight, breathing, circulation, central nervous system and extremity are movable, equal Non Apparent Abnormality reaction.
Clinical data
1 object and method
1.1 accept arteriosclerosis patient for medical treatment, totally 105 examples.Wherein man 62 example, female 43 example, all meets arteriosclerosis diagnostic criteria.At random patient is divided into 2 groups: matched group and treatment group, treatment group 55 example, matched group 50 example, acquisition and recording patient physical data and state of an illness data after being admitted to hospital, adopts APACHE II standards of grading assess patient severity extent.Two groups of patient population data and APACHE II mark more equal no significant difference (P > 0. 05).
1.2 diagnostic criterias are with reference to clinical manifestation:
Arteriosclerotic performance depends mainly on the degree of ischemia of vascular lesion and afflicted organ, for early stage arteriosclerotic, Most patients nearly all without any clinical symptoms, development of hiding under being all in concealment state.For the arteriosclerotic in mid-term, Most patients all more or less listless and aching, the limping of had palpitation, chest pain, uncomfortable in chest, headache, dizziness, the cool fiber crops of extremity, extremity, vision reduction, hypomnesis,
insomniathe clinical symptoms such as dreaminess, different patients has different symptoms.
Generally show as mental and flag, palpation body surface artery is as elongated, tortuous and hardening in Temporal Artery, radial artery, brachial artery etc. can find to broaden.
1.3 Therapeutic Method:
Treatment group: take oral liquid of the present invention, natural gift three times are taken, the morning, noon and afternoon you each one, 15 days courses for the treatment of, or take one time four, three times on the one, 15 days courses for the treatment of.
Matched group: oral folic acid, vitamin B12, extra-nutrition element.
1.4 efficacy assessment standards (1) clinical recovery: symptom, sign disappear, functional activity recovers normal, checks that indices recovers.(2) effective: symptom obviously alleviates.(3) effective: symptom alleviates slightly.(4) invalid: clinical symptoms, sign are without change.
I.5 statistical procedures uses SPSS 12.0 software to carry out statistical analysis, and ask that mean compares employing one factor analysis of variance for each group, group is asked and compared employing between two.Inspection.P<0.05 is that difference has significance.
2 results
Two groups of general curative effects compare, and the results are shown in Table 1.
A table 1 liang group general curative effect compares [example (%)]
Group | n | Cure | Effective | Effectively | Invalid | Total effective rate (%) |
Treatment group | 55 | 14(25.5) | 23(41.8) | 12(21.8) | 6(10.9) | 49(89.1) |
Matched group | 50 | 8(16.0) | 17(34.0) | 15(30.0) | 10(20.0) | 40(80.0) |
As can be seen from Table 1, adopt Chinese medicine preparation of the present invention can improve overall treatment effect to arteriosclerosis, treatment group is compared with matched group, and P<0.05, has comparability.
All above-mentioned this intellectual properties of primary enforcement, not setting restriction this new product of other forms of enforcement and/or new method.Those skilled in the art will utilize this important information, and foregoing is revised, to realize similar implementation status.But all modifications or transformation belong to the right of reservation based on new product of the present invention.
The above is only preferred embodiment of the present invention, and be not restriction the present invention being made to other form, any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the Equivalent embodiments of equivalent variations.But everyly do not depart from technical solution of the present invention content, any simple modification, equivalent variations and the remodeling done above embodiment according to technical spirit of the present invention, still belong to the protection domain of technical solution of the present invention.
Claims (6)
1. treat the Chinese medicine composition of arteriosclerosis for one kind, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of various crude drug is: Fructus Mori 10-20 part, Flos Sophorae 10-20 part, Stamen Nelumbinis 10-20 part, Semen Cuscutae 10-20 part, Radix Aconiti Lateralis Preparata 10-20 part, Semen Sesami Nigrum 10-20 part, Rhizoma Anemones Altaicae 10-20 part, Flos Caraganae intermediae 10-20 part, Caulis Spatholobi 10-20 part, Oletum Trogopterori 10-20 part, Herba Pogostemonis 10-20 part, Radix Achyranthis Bidentatae 10-20 part, Colla Corii Asini 10-20 part, Fructus Choerospondiatis 10-20 part, Flos Ginseng 10-20 part, Flos Lilii viriduli 10-20 part, Folium Ginkgo 10-20 part, Flos Albiziae 10-20 part, Folium Linderae strychnifoliae 10-20 part, Herba Cistanches 10-20 part, Arillus Longan 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Radix Curcumae 10-20 part, fresh pears 10-20 part, Fructus Citri tangerinae 10-20 part, Fructus Citri Limoniae 10-20 part, Lac regis apis 10-20 part.
2. a kind of Chinese medicine composition for the treatment of arteriosclerosis according to claim 1, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of various crude drug is: Fructus Mori 14-18 part, Flos Sophorae 14-18 part, Stamen Nelumbinis 14-18 part, Semen Cuscutae 14-18 part, Radix Aconiti Lateralis Preparata 14-18 part, Semen Sesami Nigrum 14-18 part, Rhizoma Anemones Altaicae 14-18 part, Flos Caraganae intermediae 14-18 part, Caulis Spatholobi 14-18 part, Oletum Trogopterori 14-18 part, Herba Pogostemonis 14-18 part, Radix Achyranthis Bidentatae 14-18 part, Colla Corii Asini 14-18 part, Fructus Choerospondiatis 14-18 part, Flos Ginseng 14-18 part, Flos Lilii viriduli 14-18 part, Folium Ginkgo 14-18 part, Flos Albiziae 14-18 part, Folium Linderae strychnifoliae 14-18 part, Herba Cistanches 14-18 part, Arillus Longan 14-18 part, Radix Salviae Miltiorrhizae 14-18 part, Radix Curcumae 14-18 part, fresh pears 14-18 part, Fructus Citri tangerinae 14-18 part, Fructus Citri Limoniae 14-18 part, Lac regis apis 14-18 part.
3. a kind of Chinese medicine composition for the treatment of arteriosclerosis according to claim 1, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of various crude drug is: 16 parts, Fructus Mori, 16 parts, Flos Sophorae, Stamen Nelumbinis 16 parts, Semen Cuscutae 16 parts, Radix Aconiti Lateralis Preparata 16 parts, Semen Sesami Nigrum 16 parts, Rhizoma Anemones Altaicae 16 parts, Flos Caraganae intermediae 16 parts, Caulis Spatholobi 16 parts, Oletum Trogopterori 16 parts, Herba Pogostemonis 16 parts, Radix Achyranthis Bidentatae 16 parts, 16 parts, Colla Corii Asini, Fructus Choerospondiatis 16 parts, Flos Ginseng 16 parts, Flos Lilii viriduli 16 parts, Folium Ginkgo 16 parts, Flos Albiziae 16 parts, Folium Linderae strychnifoliae 16 parts, Herba Cistanches 16 parts, Arillus Longan 16 parts, Radix Salviae Miltiorrhizae 16 parts, Radix Curcumae 16 parts, fresh pears 16 parts, Fructus Citri tangerinae 16 parts, 16 parts, Fructus Citri Limoniae, Lac regis apis 16 parts.
4. a kind of preparation method for the treatment of the Chinese medicine composition of arteriosclerosis according to claim 1-3 any one, described Chinese medicine preparation dosage form is that the preparation method of capsule comprises:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, puts into 10 times of water gagings by surplus stock, heating and refluxing extraction 3 times, each 45 minutes ~ 1 hour, is merged by 3 extracting solution and leaves standstill;
Step c, by the merging of above-mentioned two kinds of filtrates, decompression recycling ethanol to be concentrated into liquor strength be 0.4g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.06; Above-mentioned filtrate is the macroporous adsorptive resins of 10L through volume, first uses deionized water or the distilled water eluting of 10 times of resin column volumes, then uses 95% ethanol elution of 5 times of resin column volumes, collects ethanol elution, removes solvent, obtains raw material medicated powder, incapsulate.
5. a kind of preparation method for the treatment of the Chinese medicine composition of arteriosclerosis according to claim 1-3 any one, described Chinese medicine preparation dosage form is that the preparation method of oral liquid comprises:
Step a, puts into 10 times amount ethanol by Fructus Mori, Fructus Choerospondiatis, fresh pears, Fructus Citri tangerinae, Fructus Citri Limoniae, heating and refluxing extraction 2 times, each 1 ~ 2 hour, extracts active ingredient, is merged by 2 extracting solution and leaves standstill;
Step b, by surplus stock medicine, is placed in decoction pot, first time adds 3 times of water gagings, soak 3 hours, decoct 20-30 minute, leach decocting liquid, second time adds 2 times of water gagings again, decoct 20-30 minute, twice decocting liquid mixing adjusted and add extracting solution subharmonic again in step a all afterwards, being concentrated into liquor strength is 0.4g crude drug/mL oral liquid, filling device bottle, obtains oral liquid.
6. a kind of dosage form for the treatment of the Chinese medicine composition of arteriosclerosis according to claim 1-3 any one, pharmaceutical dosage form is: sugar coated tablet, film coated tablet, enteric coated tablet, oral liquid, granule, electuary, powder, sublimed preparation, solution, suppository, plaster, syrup.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510110696.8A CN104645244A (en) | 2015-03-14 | 2015-03-14 | Traditional Chinese medicine composition for treating atherosclerosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510110696.8A CN104645244A (en) | 2015-03-14 | 2015-03-14 | Traditional Chinese medicine composition for treating atherosclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104645244A true CN104645244A (en) | 2015-05-27 |
Family
ID=53237213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510110696.8A Pending CN104645244A (en) | 2015-03-14 | 2015-03-14 | Traditional Chinese medicine composition for treating atherosclerosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104645244A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105497816A (en) * | 2016-01-20 | 2016-04-20 | 姜少燕 | Traditional Chinese medicine preparation for treating atherosclerosis and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009051828A (en) * | 2007-07-30 | 2009-03-12 | Mitsubishi Tanabe Pharma Corp | Pharmaceutical composition |
CN102198236A (en) * | 2011-05-27 | 2011-09-28 | 孔建 | Chinese medicine composition for treating acute sinusitis and preparation method thereof |
CN102772491A (en) * | 2012-08-17 | 2012-11-14 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medicine composition for treating lower extremity atherosclerotic disease and application of composition |
CN102961684A (en) * | 2012-11-06 | 2013-03-13 | 王芳 | Medicament for treating arteriosclerosis |
-
2015
- 2015-03-14 CN CN201510110696.8A patent/CN104645244A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009051828A (en) * | 2007-07-30 | 2009-03-12 | Mitsubishi Tanabe Pharma Corp | Pharmaceutical composition |
CN102198236A (en) * | 2011-05-27 | 2011-09-28 | 孔建 | Chinese medicine composition for treating acute sinusitis and preparation method thereof |
CN102772491A (en) * | 2012-08-17 | 2012-11-14 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medicine composition for treating lower extremity atherosclerotic disease and application of composition |
CN102961684A (en) * | 2012-11-06 | 2013-03-13 | 王芳 | Medicament for treating arteriosclerosis |
Non-Patent Citations (2)
Title |
---|
张红星等: "《实用中西医结合老年病学》", 30 April 2007, 中国医药科技出版社 * |
王春喜等: "中西医结合治疗动脉硬化闭塞症临床观察", 《中国中西医结合杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105497816A (en) * | 2016-01-20 | 2016-04-20 | 姜少燕 | Traditional Chinese medicine preparation for treating atherosclerosis and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1330352C (en) | Health care wine and preparation method | |
CN102846824B (en) | Traditional Chinese medicinal composition for treating cold dampness blood stasis blocking channel type diabetic feet, and its preparation method | |
CN104721582A (en) | Medicine for treating hypomenorrhea due to deficiency of kidney and preparation method thereof | |
CN104274754A (en) | Traditional Chinese medicine composition for treating infantile enuresis and preparation method of traditional Chinese medicine composition | |
CN106490558A (en) | A kind of health-care honey and preparation method thereof | |
CN104548049A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
CN104758534A (en) | Medicine for treating osteoporosis and preparing method thereof | |
CN102579818A (en) | Traditional Tibetan medicine composition, preparation method thereof and application | |
CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
CN104688999A (en) | Chinese herbal preparation for immunity enhancement | |
CN104645244A (en) | Traditional Chinese medicine composition for treating atherosclerosis | |
CN104800553A (en) | Traditional Chinese medicine composition for treating climacteric insomnia and preparation method of traditional Chinese medicine composition | |
CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
CN104906394A (en) | Traditional Chinese medicine for treating liver and kidney yin deficiency and qi and blood deficiency type hypertension | |
CN104547642A (en) | Tradtional Chinese medicine composition for treating female fibromyalgia syndromes | |
Sun et al. | Basic Knowledge of Chinese Materia Medica | |
CN104547989B (en) | A kind of Tibetan medicine paste and its application method for being used to treat spondylodynia | |
CN115252700B (en) | Traditional Chinese medicine composition and medicine for treating cervical tinnitus and preparation method thereof | |
CN106692821A (en) | Traditional Chinese medicine preparation for treating neurosurgical postoperative headache | |
CN106177208A (en) | A kind of subhealth state that regulates causes the Chinese herbal and crude drugs preparations of insomnia agitation | |
CN105343647A (en) | Traditional Chinese medicine preparation for treating neurasthenia | |
CN104857371A (en) | Medicine for treating colon cancer and preparation method thereof | |
CN105434987A (en) | Traditional Chinese medicine preparation for treating cerebral infarction | |
CN104707031A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
CN105596862A (en) | Medicine used for treating and nursing postpartum dyspepsia caused by excessive eating or improper diet and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150527 |